<--- Back to Details
First PageDocument Content
Nitriles / Organofluorides / Benzamides / Lactams / MDV3100 / Thioureas / Prostate cancer / Docetaxel / Prostate / Chemistry / Organic chemistry / Anatomy
Date: 2011-11-03 09:32:07
Nitriles
Organofluorides
Benzamides
Lactams
MDV3100
Thioureas
Prostate cancer
Docetaxel
Prostate
Chemistry
Organic chemistry
Anatomy

Medivation Contacts: Patrick Machado Chief Business & Financial Officer[removed]Astellas Contacts:

Add to Reading List

Source URL: www.astellas.com

Download Document from Source Website

File Size: 129,32 KB

Share Document on Facebook

Similar Documents

Prostate cancer / Organofluorides / Prostate / Androgen receptor / MDV3100 / Galeterone / Anatomy / Biology / Medicine

Award ID: CP130020 Project Title: Androgen Receptor N-Terminus Blocker Program for Prostate Cancer Award Mechanism: Company Relocation

DocID: 19pfm - View Document

Nitriles / Organofluorides / Benzoates / Carbamates / Abiraterone / MDV3100 / Prostate cancer / Docetaxel / Bicalutamide / Chemistry / Organic chemistry / Antiandrogens

5.5 ENZALUTAMIDE, capsule, 40 mg, Xtandi®, Astellas Pharma Australia Pty Ltd, Purpose of Application Authority required (Streamlined) listing for enzalutamide for treatment of metastatic prostate cancer after treatment

DocID: 17GTi - View Document

Nitriles / Organofluorides / Benzoates / Carbamates / Abiraterone / MDV3100 / Prostate cancer / Docetaxel / Bicalutamide / Chemistry / Organic chemistry / Antiandrogens

PDF Document

DocID: 16Qjm - View Document

Cytokines / Cancer research / Nitriles / Organofluorides / CCL2 / LNCaP / Prostate cancer / MDV3100 / STAT3 / Biology / Medicine / Cell lines

Microsoft PowerPoint - Figure MQ[removed]

DocID: ZzdJ - View Document

Cancer treatments / Prostate-specific antigen / Prostate / MDV3100 / Docetaxel / Benign prostatic hyperplasia / Institute of Cancer Research / Management of cancer / Management of prostate cancer / Medicine / Prostate cancer / Abiraterone

Queensland Prostate Cancer News This magazine is a publication of the Queensland Chapter, Prostate Cancer Foundation of Australia. Letter from the Editor

DocID: YHLd - View Document